Publication Name	World Journal of Diabetes
Manuscript ID	20657
Country	Australia

Received	2015-06-15 15:56
Peer-Review Started	2015-06-17 08:09
To Make the First Decision	2015-07-27 18:36
Return for Revision	2015-07-31 19:01
Revised	2015-08-11 16:24
Second Decision	2015-10-08 13:30
Accepted by Journal Editor-in-Chief	2015-10-08 18:52
Accepted by Executive Editor-in-Chief	2015-10-19 15:12
Articles in Press	2015-10-19 15:23
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-10-20 11:33
Publish the Manuscript Online	2015-10-26 10:17

ISSN	1948-9358 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Review
Article Title	Whey protein: The “whey” forward for treatment of type 2 diabetes?
Manuscript Source	Invited Manuscript
All Author List	Linda E Mignone, Tongzhi Wu, Michael Horowitz and Christopher K Rayner
Funding Agency and Grant Number	Funding Agency Grant Number Royal Adelaide Hospital Dawes Scholarship to Mignone LE Royal Adelaide Hospital Research Committee Early Career Fellowship to Wu T National Health and Medical Research Council funding APP1066835
Corresponding Author	Christopher K Rayner, MBBS, PhD, Professor, Discipline of Medicine, the University of Adelaide, Frome Road Adelaide, Adelaide 5000, Australia. chris.rayner@adelaide.edu.au
Key Words	Whey protein; Postprandial glycaemia; Type 2 diabetes; Dietary intervention; Preload; Gastric emptying; Incretins; Gut hormones; Amino acids; Appetite
Core Tip	Whey protein, a by-product of cheese-manufacture, shows promise in the dietary management of diabetes. Whey can slow gastric emptying, stimulate insulin and gut hormones including the incretins, and thereby reduce postprandial blood glucose, especially when consumed some minutes before a meal. Whey may also suppress appetite and reduce food intake. This review will summarise these properties of whey and examine what further evidence is needed before whey can be recommended in the management of type 2 diabetes.
Publish Date	2015-10-26 10:17
Citation	Mignone LE, Wu T, Horowitz M, Rayner CK. Whey protein: The “whey” forward for treatment of type 2 diabetes? World J Diabetes 2015; 6(14): 1274-1284
URL	http://www.wjgnet.com/1948-9358/full/v6/i14/1274.htm
DOI	http://dx.doi.org/10.4239/wjd.v6.i14.1274

Full Article (PDF)	WJD-6-1274.pdf
Full Article (Word)	WJD-6-1274.doc
Manuscript File	20657-Review.docx
Answering Reviewers	20657-Answering reviewers.pdf
Audio Core Tip	20657-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	20657-Conflict-of-interest statement.pdf
Copyright License Agreement	20657-Copyright assignment.pdf
Peer-review Report	20657-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	20657-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	20657-Scientific misconduct check.pdf
Scientific Editor Work List	20657-Scientific editor work list.pdf